nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—ID2—ocular cancer	0.0416	0.0416	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—E2F5—ocular cancer	0.0384	0.0384	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—E2F4—ocular cancer	0.0376	0.0376	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—RBL1—ocular cancer	0.0369	0.0369	CbGpPWpGaD
Nilutamide—AR—Notch-mediated HES/HEY network—MAML2—ocular cancer	0.0365	0.0365	CbGpPWpGaD
Nilutamide—AR—Coregulation of Androgen receptor activity—CCND3—ocular cancer	0.0338	0.0338	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—RBBP4—ocular cancer	0.032	0.032	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—TFDP1—ocular cancer	0.0297	0.0297	CbGpPWpGaD
Nilutamide—AR—Notch-mediated HES/HEY network—HDAC1—ocular cancer	0.0267	0.0267	CbGpPWpGaD
Nilutamide—AR—Coregulation of Androgen receptor activity—CDK6—ocular cancer	0.0252	0.0252	CbGpPWpGaD
Nilutamide—AR—Regulation of Androgen receptor activity—HDAC1—ocular cancer	0.0243	0.0243	CbGpPWpGaD
Nilutamide—AR—Notch-mediated HES/HEY network—E2F1—ocular cancer	0.022	0.022	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.0189	0.0189	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.0186	0.0186	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—CDC25A—ocular cancer	0.0185	0.0185	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND2—ocular cancer	0.0175	0.0175	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—HDAC1—ocular cancer	0.0175	0.0175	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—HDAC1—ocular cancer	0.0173	0.0173	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—HDAC1—ocular cancer	0.016	0.016	CbGpPWpGaD
Nilutamide—AR—Notch-mediated HES/HEY network—RB1—ocular cancer	0.0156	0.0156	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—ocular cancer	0.0155	0.0155	CbGpPWpGaD
Nilutamide—AR—FOXA1 transcription factor network—CDKN1B—ocular cancer	0.0128	0.0128	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—CDK2—ocular cancer	0.0123	0.0123	CbGpPWpGaD
Nilutamide—AR—Notch-mediated HES/HEY network—CDKN1B—ocular cancer	0.0121	0.0121	CbGpPWpGaD
Nilutamide—AR—Regulation of Androgen receptor activity—MDM2—ocular cancer	0.0121	0.0121	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—CDK4—ocular cancer	0.0116	0.0116	CbGpPWpGaD
Nilutamide—AR—FOXA1 transcription factor network—EP300—ocular cancer	0.0112	0.0112	CbGpPWpGaD
Nilutamide—AR—Notch-mediated HES/HEY network—EP300—ocular cancer	0.0106	0.0106	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—HDAC1—ocular cancer	0.0105	0.0105	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—HDAC1—ocular cancer	0.0102	0.0102	CbGpPWpGaD
Nilutamide—AR—Nongenotropic Androgen signaling—HRAS—ocular cancer	0.0102	0.0102	CbGpPWpGaD
Nilutamide—AR—Regulation of Androgen receptor activity—EP300—ocular cancer	0.00967	0.00967	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—E2F5—ocular cancer	0.00961	0.00961	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—E2F4—ocular cancer	0.00941	0.00941	CbGpPWpGaD
Nilutamide—AR—Coregulation of Androgen receptor activity—CCND1—ocular cancer	0.00939	0.00939	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—RB1—ocular cancer	0.00935	0.00935	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—RBL1—ocular cancer	0.00923	0.00923	CbGpPWpGaD
Nilutamide—AR—Nongenotropic Androgen signaling—AKT1—ocular cancer	0.00898	0.00898	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—E2F1—ocular cancer	0.00864	0.00864	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—MDM2—ocular cancer	0.00797	0.00797	CbGpPWpGaD
Nilutamide—AR—Gene Expression—SF3B1—ocular cancer	0.00789	0.00789	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.0078	0.0078	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—ocular cancer	0.00756	0.00756	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—CDK2—ocular cancer	0.00745	0.00745	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—TFDP1—ocular cancer	0.00744	0.00744	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—ocular cancer	0.00724	0.00724	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.00716	0.00716	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—CDK4—ocular cancer	0.00704	0.00704	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—ocular cancer	0.00696	0.00696	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—CCND1—ocular cancer	0.00694	0.00694	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—EP300—ocular cancer	0.00689	0.00689	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—CDKN1A—ocular cancer	0.00671	0.00671	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—EP300—ocular cancer	0.00639	0.00639	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.00617	0.00617	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—RB1—ocular cancer	0.00612	0.00612	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—ocular cancer	0.00606	0.00606	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—MYC—ocular cancer	0.006	0.006	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—MAML2—ocular cancer	0.00591	0.00591	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.00583	0.00583	CbGpPWpGaD
Nilutamide—AR—Gene Expression—EIF1AX—ocular cancer	0.00556	0.00556	CbGpPWpGaD
Nilutamide—AR—Coregulation of Androgen receptor activity—AKT1—ocular cancer	0.00522	0.00522	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—MDM2—ocular cancer	0.00522	0.00522	CbGpPWpGaD
Nilutamide—AR—Gene Expression—E2F5—ocular cancer	0.00462	0.00462	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—CCND1—ocular cancer	0.00455	0.00455	CbGpPWpGaD
Nilutamide—AR—Gene Expression—E2F4—ocular cancer	0.00453	0.00453	CbGpPWpGaD
Nilutamide—AR—Gene Expression—RPL39—ocular cancer	0.00444	0.00444	CbGpPWpGaD
Nilutamide—AR—Gene Expression—RBL1—ocular cancer	0.00444	0.00444	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.00433	0.00433	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—HDAC1—ocular cancer	0.00432	0.00432	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—EP300—ocular cancer	0.00419	0.00419	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—ocular cancer	0.00416	0.00416	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—EP300—ocular cancer	0.00408	0.00408	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.00395	0.00395	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—CDKN2B—ocular cancer	0.00387	0.00387	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—AKT1—ocular cancer	0.00386	0.00386	CbGpPWpGaD
Nilutamide—AR—Gene Expression—RBBP4—ocular cancer	0.00385	0.00385	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.00377	0.00377	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—MYC—ocular cancer	0.00365	0.00365	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.00364	0.00364	CbGpPWpGaD
Nilutamide—AR—Gene Expression—TFDP1—ocular cancer	0.00358	0.00358	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.00347	0.00347	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.00302	0.00302	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.00301	0.00301	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—TP53—ocular cancer	0.003	0.003	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PSPH—ocular cancer	0.00287	0.00287	CbGpPWpGaD
Nilutamide—AR—Gene Expression—MAML2—ocular cancer	0.00285	0.00285	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PSPH—ocular cancer	0.00256	0.00256	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—AKT1—ocular cancer	0.00253	0.00253	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.00248	0.00248	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PSPH—ocular cancer	0.00234	0.00234	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.0021	0.0021	CbGpPWpGaD
Nilutamide—AR—Gene Expression—HDAC1—ocular cancer	0.00208	0.00208	CbGpPWpGaD
Nilutamide—AR—Gene Expression—CDKN2B—ocular cancer	0.00186	0.00186	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—MYC—ocular cancer	0.0015	0.0015	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GNA11—ocular cancer	0.000903	0.000903	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GNAQ—ocular cancer	0.00084	0.00084	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GNA11—ocular cancer	0.000806	0.000806	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GNAQ—ocular cancer	0.000749	0.000749	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GNA11—ocular cancer	0.000735	0.000735	CbGpPWpGaD
Nilutamide—AR—Gene Expression—MYC—ocular cancer	0.000723	0.000723	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GNAQ—ocular cancer	0.000683	0.000683	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000677	0.000677	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000605	0.000605	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000551	0.000551	CbGpPWpGaD
Nilutamide—AR—Gene Expression—AKT1—ocular cancer	0.000501	0.000501	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—EP300—ocular cancer	0.000302	0.000302	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—EP300—ocular cancer	0.000269	0.000269	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—EP300—ocular cancer	0.000246	0.000246	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—AKT1—ocular cancer	0.000182	0.000182	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—AKT1—ocular cancer	0.000163	0.000163	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—AKT1—ocular cancer	0.000148	0.000148	CbGpPWpGaD
